Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Embryonics Oy
OY
Dissolved
Y-tunnus 2401957-4
Harjuviita 14C-1427, 02110
Espoo
Business and other management consultancy activities
·
NACE 7020
Est. 2011 · 15 years old
— employees
Share
Finland
/
Companies
/
Business and other management consultancy activities
/
Embryonics Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2024
0M
2025
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2024
0M
0%
2025
Income statement
EUR thousands
Item
2020
2021
2022
2024
2025
Revenue
—
—
2
0
0
Staff expenses
—
—
—
−0
−0
EBITDA
−5
−2
1
−1
−1
Depreciation & amort.
—
—
—
−0
−0
EBIT
−5
−2
1
−1
−1
Net financials
2
2
−0
2
2
Profit before tax
−3
0
1
2
2
Tax
−0
−0
−0
−0
−0
Net profit
−3
0
1
2
2
Balance sheet
EUR thousands
Item
2020
2021
2022
2024
2025
Total assets
287
287
298
303
303
Equity
242
242
244
5
5
Long-term debt
—
—
—
0
0
Short-term debt
45
45
55
246
248
Total debt
45
45
55
246
248
Financial ratios
5-year trend
EBITDA-margin
-79200.0%
This company
15.8%
Market median
-501366% vs market
2020
2025
Soliditetsgrad
1.5%
This company
38.2%
Market median
-96% vs market
2020
2025
Egenkapitalforrentning
34.9%
This company
18.4%
Market median
+90% vs market
2020
2025
Nettoresultatgrad
160800.0%
This company
8.1%
Market median
+1985085% vs market
2020
2025
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2020
2025
Gæld/egenkapital
64.80×
This company
0.62×
Market median
-10352% vs market
2020
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
View
PDF
More on Embryonics Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
